Tagomics

Tagomics is a pioneering company in the field of multiomics, focusing on developing advanced epigenomic-based technologies for clinical applications. The company serves healthcare providers, research institutions, and pharmaceutical companies, operating within the biotechnology and healthcare markets. Tagomics' business model revolves around creating high-throughput and cost-effective solutions for comprehensive disease profiling, which helps in accelerating disease understanding and diagnosis. Revenue is generated through the sale of its proprietary technologies and services, as well as potential partnerships and collaborations with other entities in the healthcare sector.

Keywords: multiomics, epigenomics, disease profiling, biotechnology, healthcare, clinical applications, high-throughput, economical, diagnostics, research institutions.